Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study.
about
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@en
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@nl
type
label
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@en
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@nl
prefLabel
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@en
Ursodeoxycholic acid potentiat ...... d controlled and add-on study.
@nl
P2093
P2860
P1476
Ursodeoxycholic acid potentiat ...... ed controlled and add-on study
@en
P2093
Hirofumi Misu
Ken-Ichiro Kato
Shuichi Kaneko
Tsuguhito Ota
Yumie Takeshita
P2860
P304
P356
10.1136/BMJDRC-2017-000469
P577
2018-03-17T00:00:00Z